In line with outgoing FDA Commissioner Scott Gottlieb's push to modernize drug, biologic and device development, FDA released additional guidances Thursday to help sponsors design trials more efficiently, including a framework on targeted drug and biologic development.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,